Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.47 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4838971 | 0.96 | CETP (0.52) | CETPPOLBALOX5SMN1; SMN2CYP4F2 | |
| SCHEMBL31308108 | 0.83 | CETP (0.55) | CETPALOX5SMN1; SMN2TSHR | |
| SCHEMBL28016562 | 0.82 | ALDH1A1 (0.58) | ALOX5SMN1; SMN2CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL30887317 | 0.81 | CETP (0.57) | CETPSMN1; SMN2TSHR | |
| SCHEMBL417168 | 0.81 | CETP (0.50) | CETPPOLBSMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL7050932 | 0.80 | CETP (0.52) | CETPALDH1A1TSHRLPAR1L3MBTL1 | |
| SCHEMBL24768581 | 0.79 | ALDH1A1 (0.58) | ALOX5SMN1; SMN2CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL7265466 | 0.79 | CETP (0.71) | CETPTSHR | |
| SCHEMBL4931741 | 0.79 | CYP1A2 (0.50) | CYP4F2CYP4A11ALDH1A1TSHRLPAR1 | |
| SCHEMBL3047517 | 0.79 | ALDH1A1 (0.50) | CETPPOLBSMN1; SMN2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543893-A1 | N-SUBSTITUTED INDOLE DERIVATIVES AND CONJUGATES FOR THE TREATMENT OF CANCER | Evexta Bio (FR) | 2025-04-30 | — | — | EP | disclosed |
| WO-2024003002-A1 | N-SUBSTITUTED INDOLE DERIVATIVES AND CONJUGATES FOR THE TREATMENT OF CANCER | DIACCURATE (FR) | 2024-01-04 | — | — | WO | disclosed |